Brain scans and a painkiller may unlock Depression's secrets

NCT ID NCT04276259

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study looked at how the brain processes reward signals to improve mood in people with depression. Researchers used brain scans, a mild magnetic stimulation technique (TMS), and a single injection of buprenorphine (a painkiller) to see how these affect brain activity. The goal was to understand the brain mechanisms behind mood improvement, not to test a new treatment. 120 adults with depressive symptoms took part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

buprenorphine

What this could lead to

If successful, this could reveal how the brain's reward system influences mood, pointing toward new ways to treat depression.

What could go wrong

This is a small, early-stage study focused on brain mechanisms, not a treatment trial. Results may not lead to a direct therapy or apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bellefield Tower

    Pittsburgh, Pennsylvania, 15213, United States